Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
22.90
+0.44 (1.96%)
At close: Jun 26, 2026, 4:00 PM EDT
22.70
-0.20 (-0.87%)
After-hours: Jun 26, 2026, 6:58 PM EDT

Nurix Therapeutics Statistics

Total Valuation

NRIX has a market cap or net worth of $2.37 billion. The enterprise value is $1.89 billion.

Market Cap 2.37B
Enterprise Value 1.89B

Important Dates

The next estimated earnings date is Wednesday, July 8, 2026, after market close.

Earnings Date Jul 8, 2026
Ex-Dividend Date n/a

Share Statistics

NRIX has 103.41 million shares outstanding. The number of shares has increased by 25.59% in one year.

Current Share Class 103.41M
Shares Outstanding 103.41M
Shares Change (YoY) +25.59%
Shares Change (QoQ) +15.76%
Owned by Insiders (%) 0.50%
Owned by Institutions (%) 92.69%
Float 82.41M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 32.99
Forward PS 15.00
PB Ratio 4.92
P/TBV Ratio 4.92
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 26.27
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.01, with a Debt / Equity ratio of 0.12.

Current Ratio 6.01
Quick Ratio 5.89
Debt / Equity 0.12
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -61.40% and return on invested capital (ROIC) is -37.64%.

Return on Equity (ROE) -61.40%
Return on Assets (ROA) -31.50%
Return on Invested Capital (ROIC) -37.64%
Return on Capital Employed (ROCE) -57.97%
Weighted Average Cost of Capital (WACC) 14.18%
Revenue Per Employee $226,432
Profits Per Employee -$931,483
Employee Count 317
Asset Turnover 0.11
Inventory Turnover n/a

Taxes

In the past 12 months, NRIX has paid $760,000 in taxes.

Income Tax 760,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +97.07% in the last 52 weeks. The beta is 1.87, so NRIX's price volatility has been higher than the market average.

Beta (5Y) 1.87
52-Week Price Change +97.07%
50-Day Moving Average 16.96
200-Day Moving Average 15.35
Relative Strength Index (RSI) 82.12
Average Volume (20 Days) 3,708,250

Short Selling Information

The latest short interest is 20.02 million, so 19.37% of the outstanding shares have been sold short.

Short Interest 20.02M
Short Previous Month 19.32M
Short % of Shares Out 19.37%
Short % of Float 24.30%
Short Ratio (days to cover) 7.15

Income Statement

In the last 12 months, NRIX had revenue of $71.78 million and -$295.28 million in losses. Loss per share was -$3.17.

Revenue 71.78M
Gross Profit -259.60M
Operating Income -315.30M
Pretax Income -294.52M
Net Income -295.28M
EBITDA -307.31M
EBIT -315.30M
Loss Per Share -$3.17
Full Income Statement

Balance Sheet

The company has $540.73 million in cash and $58.66 million in debt, giving a net cash position of $482.08 million or $4.66 per share.

Cash & Cash Equivalents 540.73M
Total Debt 58.66M
Net Cash 482.08M
Net Cash Per Share $4.66
Equity (Book Value) 480.89M
Book Value Per Share 4.65
Working Capital 462.20M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$260.29 million and capital expenditures -$11.56 million, giving a free cash flow of -$271.85 million.

Operating Cash Flow -260.29M
Capital Expenditures -11.56M
Depreciation & Amortization 7.99M
Net Borrowing n/a
Free Cash Flow -271.85M
FCF Per Share -$2.63
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -439.26%
Pretax Margin -410.31%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

NRIX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -25.59%
Shareholder Yield -25.59%
Earnings Yield -12.47%
FCF Yield -11.48%

Analyst Forecast

The average price target for NRIX is $31.44, which is 37.29% higher than the current price. The consensus rating is "Strong Buy".

Price Target $31.44
Price Target Difference 37.29%
Analyst Consensus Strong Buy
Analyst Count 16
Revenue Growth Forecast (3Y) 28.99%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

NRIX has an Altman Z-Score of 1.31 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.31
Piotroski F-Score 1